Illustration for: FDA Approves First Daily Pill for Weight Loss
AI-generated illustration. Visual interpretation does not represent real individuals or scenes.

FDA Approves First Daily Pill for Weight Loss

2025-12-24

The BareStory

The U.S. Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy. The approval makes it the first daily oral medication sanctioned by the federal agency for the treatment of obesity.

The new prescription drug is a different formulation of the existing medication Wegovy. This version is designed to be administered as a pill taken once per day by patients.

According to one report, the pills are expected to be available in several weeks. The same report noted that the FDA also recently approved a non-hormonal drug for menopause and a separate medication for menopausal hot flashes.

Left Perspective

  • The approval marks a major milestone in obesity treatment.
  • The new pill offers a convenient method of administration.
  • This is part of a trend of recent FDA approvals for common conditions.

Right Perspective

  • The drug is a new formulation, not a fundamentally new medication.
  • The medication's public availability is not immediate.
  • Access to the new drug will be regulated.

How it may affect me

As a U.S. reader:

• A new daily prescription pill for obesity will be a new treatment option, offering a different formulation of the existing drug Wegovy.

• The new medication is expected to be available in several weeks, indicating a short-term delay between its approval and when patients can get it.

• This is part of a recent trend of new FDA-approved drugs for common conditions, which could mean more prescription treatment options for the public.

Read the story at